These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27835064)

  • 1. Considerations for the rational design of a Chlamydia vaccine.
    Liang S; Bulir D; Kaushic C; Mahony J
    Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
    Rey-Ladino J; Ross AG; Cripps AW
    Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Chlamydia trachomatis Vaccinology.
    de la Maza LM; Zhong G; Brunham RC
    Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
    Yu H; Karunakaran KP; Jiang X; Brunham RC
    Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
    Hafner LM; Timms P
    Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a Chlamydia trachomatis vaccine: how close are we?
    Cochrane M; Armitage CW; O'Meara CP; Beagley KW
    Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Poston TB; Gottlieb SL; Darville T
    Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
    Brunham RC; Rey-Ladino J
    Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
    Poston TB; Darville T
    Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus core antigen as a carrier for Chlamydia trachomatis MOMP multi-epitope peptide enhances protection against genital chlamydial infection.
    Jiang P; Du W; Xiong Y; Lv Y; Feng J; Zhu S; Xue X; Chen S; Zhang L
    Oncotarget; 2015 Dec; 6(41):43281-92. PubMed ID: 26657117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice.
    Paes W; Brown N; Brzozowski AM; Coler R; Reed S; Carter D; Bland M; Kaye PM; Lacey CJN
    Vaccine; 2016 Jul; 34(35):4123-4131. PubMed ID: 27389169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential for vaccine development against chlamydial infection and disease.
    Brunham RC; Zhang DJ; Yang X; McClarty GM
    J Infect Dis; 2000 Jun; 181 Suppl 3():S538-43. PubMed ID: 10839755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
    Agrawal T; Vats V; Salhan S; Mittal A
    J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
    Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
    Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis.
    Coler RN; Bhatia A; Maisonneuve JF; Probst P; Barth B; Ovendale P; Fang H; Alderson M; Lobet Y; Cohen J; Mettens P; Reed SG
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):258-70. PubMed ID: 19281568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.
    Chavez JM; Vicetti Miguel RD; Cherpes TL
    Infect Dis Obstet Gynecol; 2011; 2011():754060. PubMed ID: 22144851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
    Beagley KW; Timms P
    J Reprod Immunol; 2000 Aug; 48(1):47-68. PubMed ID: 10996382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.
    Vasilevsky S; Greub G; Nardelli-Haefliger D; Baud D
    Clin Microbiol Rev; 2014 Apr; 27(2):346-70. PubMed ID: 24696438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.